These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29740870)

  • 41. Redefining the therapeutic objective in psoriatic patients candidates for biological therapy.
    Carretero G; Puig L; Carrascosa JM; Ferrándiz L; Ruiz-Villaverde R; de la Cueva P; Belinchon I; Vilarrasa E; Del Rio R; Sánchez-Carazo JL; López-Ferrer A; Peral F; Armesto S; Eiris N; Mitxelena J; Vilar-Alejo J; A Martin M; Soria C;
    J Dermatolog Treat; 2018 Jun; 29(4):334-346. PubMed ID: 29099667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
    Lambert J; Hol CW; Vink J
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2349-55. PubMed ID: 26337069
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of plaque psoriasis in adults].
    Müller S; Schultes D; Wilsmann-Theis D
    Hautarzt; 2020 Mar; 71(3):227-243. PubMed ID: 32130433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infliximab in psoriasis and psoriatic arthritis.
    Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A
    BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
    Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
    J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An update on topical therapies for mild-moderate psoriasis.
    van de Kerkhof PC
    Dermatol Clin; 2015 Jan; 33(1):73-7. PubMed ID: 25412784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
    Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
    J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring.
    Alinia H; Moradi Tuchayi S; Smith JA; Richardson IM; Bahrami N; Jaros SC; Sandoval LF; Farhangian ME; Anderson KL; Huang KE; Feldman SR
    Br J Dermatol; 2017 Mar; 176(3):759-764. PubMed ID: 27664969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Back to the future: a new topical approach for mild-to-moderate psoriasis.
    Girolomoni G; Calzavara Pinton P; Cristaudo A; Cicchetti A
    G Ital Dermatol Venereol; 2018 Jun; 153(3):375-382. PubMed ID: 27982547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of psoriasis: an algorithm-based approach for primary care physicians.
    Pardasani AG; Feldman SR; Clark AR
    Am Fam Physician; 2000 Feb; 61(3):725-33, 736. PubMed ID: 10695585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP).
    Teixeira A; Oliveira C; Teixeira M; Rita Gaio A; Lobo JMS; de Almeida IFM; Almeida V
    Am J Clin Dermatol; 2017 Aug; 18(4):571-581. PubMed ID: 28321796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
    Feldman SR; Koo JY; Johnson LA; Preston NJ
    Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
    Feldman SR; Winkelman W; Baum E; Preston N
    J Drugs Dermatol; 2013 Dec; 12(12):1456-60. PubMed ID: 24301248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The AWARE study: methodology and baseline characteristics.
    Bissonnette R; Searles G; Landells I; Shear NH; Papp K; Lui H; Gulliver WP; Lynde C
    J Cutan Med Surg; 2009 Dec; 13 Suppl 3():S113-21. PubMed ID: 20053323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Juvenile psoriasis: an epidemiological study of 69 cases.
    Arese V; Albini P; Ibba F; Panzone M; Cervetti O
    G Ital Dermatol Venereol; 2018 Aug; 153(4):469-472. PubMed ID: 27374182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO-INSIGHTFUL study.
    Hong CH; Papp KA; Lophaven KW; Skallerup P; Philipp S
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1876-1883. PubMed ID: 28796913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].
    Ortonne JP; Shear N; Shumack S; Henninger E;
    BMC Dermatol; 2005 Dec; 5():13. PubMed ID: 16359548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Topical psoriasis therapy.
    Federman DG; Froelich CW; Kirsner RS
    Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.